- Peptide Receptor Radionuclide Therapy and the Treatment of Gastroentero-pancreatic Neuroendocrine Tumors: Current Findings and Future Perspectives
-
Hirmas N, Jadaan R, Al-Ibraheem A
- KMID: 2414809
- Nucl Med Mol Imaging.
- 2018 Jun;52(3):190-199.
- doi: 10.1007/s13139-018-0517-x
PURPOSE AND METHODS: Patients with inoperable andmetastasized neuroendocrine tumors (NETs), particularly those with grades 1 and 2, usually receive treatment with somatostatin analogues (SSAs). Peptide receptor radionuclide therapy (PRRT) has... -
- CITED
-
- Close
- SHARE
-
- Close
